Sacral neuromodulation for treatment of lower urinary tract dysfunction

BJU International, Supplement

Volumn 85, Issue 3, 2000, Pages 10-19

  Donovan, J L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONSERVATIVE TREATMENT; DETRUSOR DYSSYNERGIA; ELECTRODE; HUMAN; NEUROMODULATION; PAIN; PRIORITY JOURNAL; REVIEW; SACRUM; TREATMENT OUTCOME; URINARY DIVERSION; URINARY TRACT DISEASE;

ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; HUMANS; REFLEX; URINARY BLADDER; URINATION; URINATION DISORDERS;

EID: 0342657185     PISSN: 14655101     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (68)

1. Boyarsky S, Jones G, Paulson DF, Prout GR. New look at bladder neck obstruction by the Food and Drug Administration regulators. Am Assoc Genito-Urinary Surg 1977; 68: 29-32
2. Madsen PO, Iversen P. A point system for selecting operative candidates. In Hinman F, ed. Benign Prostatic Hypertrophy. New York: Springer-Verlag, 1983: 763-5
3. Follick M, Ahern D, Laser-Wolston N. Evaluation of a daily activity diary for chronic low back pain. Pain 1984; 19: 373-82
4. Fowler FJ Jr, Wennberg JF, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D. Symptom status and quality of life following prostatectomy. JAMA 1988; 259: 3018-22
5. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59-62
6. Barry MJ, Fowler FJ, O'Leary MP et al. The American Urological Association Symptom Index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
7. Cockett ATK, Khoury S, Aso Y et al, eds. Proceedings of the Second International Consultation on Benign Prostatic Hyperplasia. Jersey: Scientific Communication International Ltd 1993
8. Bolognese JA, Kozloff RC, Kunitz SC, Grino PB, Patrick DL, Stoner E. Validation of a symptoms questionnaire for benign prostatic hyperplasia. Prostate 1992; 21: 247-54
9. Donovan JL, Abrams P, Peters TJ et al. The ICS-'BPH' Study: the psychometric validity and reliability of the ICSmale questionnaire. Br J Urol 1996; 77: 554-62
10. Meyhoff H-H, Hald T, Nordling J. Thorup Anderson J, Blide T, Walter S. A new patient weighted symptom score system (DAN-PSS-1). Scand J Urol Nephrol 1993; 27: 493-9
11. Hansen BJ, Flyger H, Brasso K et al. Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol 1995; 76: 451-8
12. Brazier JE, Harper R, Jones NMB et al. Validating the SF-36 health survey questionnaire - new outcome measure for primary care. Br Med J 1992; 305: 160-4
13. Fowler FJ, Barry MJ, Lu-Yao G, Wasson J, Roman AMA, Wennberg J. Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare Survey. Urology 1995; 45: 1007-15
14. Donovan JL, Kay HE, Peters TJ et al. Using ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-'BPH' study. Br J Urol 1997; 80: 712-21
15. Frankel SJ, Donovan JL, Peters TJ et al. Sexual dysfunction in men with lower urinary tract symptoms. J Clin Epidemiol 1998; 51: 677-85
16. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol 1994; 74: 551-5
17. Peters TJ, Donovan JL, Kay HE et al. The International Continence Society 'Benign Prostatic Hyperplasia' Study: The bothersomeness of urinary symptoms. J Urol 1997; 157: 885-9
18. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol 1996; 77: 805-12
19. Streiner DL, Norman GR. Health Measurement Scales. Oxford: OUP, 1989
20. de la Rosette JJMCH, Witjes WPJ, Schäfer W et al. Relationships between lower urinary tract symptons and bladder outlet obstruction: results from the ICS-BPH study. Neurourol Urodynam 1998; 17: 99-108
21. Barry MJ, Cockett ATK, Holtgrewe HL, McConnell JD, Sihelnik SA, Winfield HN. Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 1993; 150: 351-8
22. Ezz El Din K, Koch WFRM, De Wildt MJAM, Kiemeney LALM, Debruyne FMJ, de La Rosette JJMCH. Reliability of the International Prostate Symptom Score in the assessment of patients with lower urinary tract symptoms and/or benign prostatic hyperplasia. J Urol 1996; 155: 1959-64
23. Sciarra A, D'Eramo G, Casale P et al. Relationships among symptoms score, prostate volume and urinary flow rates in 543 patients with and without benign prostatic hyperplasia. Prostate 1998; 34: 121-8
24. Cockett ATK, Aso Y, Chatelain C et al. eds, The International Consultation on Benign Prostatic Hyperplasia, Paris 1991. Jersey: Scientific International 1991
25. Cockett AT, Asa Y, Denis L et al. Recommendations of the International Consensus Committee. In Cockett ATK, Koury S, Aso Y, Chatelain C, Denis L, Griffiths K, eds, Third International Consultation on BPH. Jersey: Scientific Communication International, 1996: 625-39
26. Hansen BJ, Mortensen S, Mensink HJA et al. Comparison of the Danish prostate symptom score with the IPSS, Madsen-Iversen and Boyarsky symptom indexes. Br J Urol 1998; 81 : 36-41
27. Donovan JL, Brookes ST, de la Rosette JJMCH et al. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study. BJU Int 1999; 83: 243-8
28. Witjes WPJ, de la Rosette JJMCH, Donovan JL et al. The ICS-'BPH' study: International differences in lower urinary tract symptoms and related bother. J Urol 1997; 157: 1295-300
29. Guess HA, Chute CG, Garraway WM et al. Similar levels of urological symptoms have similar impact on Scottish and American men - although Scots report less symptoms. J Urol 1993; 150: 1701-5
30. Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32
31. Abrams P, Donovan JL, de la Rosette JJMCH, Schäfer W and the ICS-'BPH' Study Group. International Continence Society 'Benign Prostatic Hyperplasia' study: background, aims and methodology. Neurourol Urodynam 1997; 16: 79-91
32. World Health Organisation. Definition of Health. Geneva: WHO 1978
33. Patrick DL, Bergner M. Measurement of health status in the 1990s. Ann Rev Public Health 1990; 11: 165-83
34. Lukacs B, Leplege A, Thibault P et al. Development, validation and application of a BPH-specific health-related quality of life questionnaire. In Cockett ATK, Koury S, Aso Y et al, eds. Proceedings of the Third International Consultation BPH, Monaco. Jersey: Scientific International, 1996: 277-80
35. Tsang KK, Garraway WM. Impact of benign prostatic hyperplasia on general well-being of men. Prostate 1993; 23: 1-7
36. Sagnier P, MacFarlene G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol 1995; 153: 669-73
37. Anonymous. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostalic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993; 150: 1696-700
38. Emberton M, Neal D, Black N et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol 1996; 77: 233-47
39. Fowler FJ Jr, Barry MJ. Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index. Eur Urol 1993; 24: 24-7
40. Chute CG, Panser LA, Girman CJ et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993; 150: 85-9
41. Hunter DJW, McKee CM, Black N, Sanderson CFB. Urinary symptoms: prevalence and severity in British men aged 55 and over. J Epidemiol Community Health Med 1994; 48: 569-75
42. Garraway WM, Russell EBA, Lee RJ et al. Impact of previously unrecognised benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract 1993; 43: 318-21
43. Girman CJ, Epstein RS, Jacobsen SJ et al. Natural history of prostatism: Impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology 1994; 44: 825-31
44. Doll H, McPherson K, Davies J et al. Reliability of questionnaire responses as compared with interview in the elderly: views of the outcome of transurethral resection of the prostate. Soc Sci Med 1991; 33: 1303-8
45. Hunskaar S, Vinsnes A. The quality of life in women with urinary incontinence as measured by the sickness impact profile. J Am Geriatr Soc 1991; 39: 378-82
46. Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Aging 1993; 22: 82-9
47. The EuroQol Group. EuroQol - a new facility for the measurement of health related quality of life. Health Policy 1990; 16: 199-208
48. Gudex C, Macdonagh R. Change in reported health status following urological surgery: preliminary results. Eroqol plenary meeting, Rotterdam 6-8 October; discussion papers. 1999
49. Macdonagh RP, Cliff AM, Speakman MJ, O'Boyle PJ, Ewings P, Gudex C. The use of generic measures of health-related quality of life in the assessment of outcome from TURP. Br J Urol 1997; 79: 401-8
50. Barry M, Fowler F, O'Leary M, Bruskewitz R, Holtgrewe H, Mebust W. Measuring disease-specific health status in men with benign prostatic hyperplasia. Med Care 1995; 33: AS145-AS155
51. Lukacs B, Comet D, Grange JC, Thibault P. Construction and validation of a short form benign prostatic hypertrophy health-related quality-of-life questionnaire. Br J Urol 1997; 80: 722-30
52. Epstein RS, Deverka PA, Chute CG et al. Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol 1992; 45: 1431-45
53. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J Roy Coll Gen Pract 1985; ??: 185-8
54. Hunter JW, McKec M, Black NA. Health status and quality of life of British men with lower urinary tract symptoms: Results from the SF-36. Urology 1995; 45: 962-71
55. Litwin MS, Hays RD, Fink A et al. Quality of life outcomes in men treated for localized prostate cancer. JAMA 1995; 273: 129-35
56. Lukacs B, McCarthy C, Grange JC. Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,09 3 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice. Eur Urol 1993; 24 (Suppl 1): 34-40
57. Epstein RS, Deverka PA, Chute CG et al. Urinary symptom and quality of life questions indicative of obstructive benign prostatic hyperplasia. Results of a pilot study. Urology 1991 ; 38: 20-6
58. Jacobscn SJ, Girman CJ, Guess HA et al. Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. Urology 1993; 42: 663-71
59. Eri LM, Tveter KJ. Measuring the quality of life of patients with benign prostatic hyperplasia, assessment of the usefulness of a new quality of life questionnaire specially adapted to benign prostatic hyperplasia patients. Eur Urol 1992; 21: 257-62
60. Macfarlane GJ, Botto H, Sagnier PP, Teillac P, Richard F, Boyle P. The relationship between sexual life and urinary condition in the French community. J Clin Epidemiol 1996; 49: 1171-6
61. Doll HA, Black NA, McPherson K, Williams GB, Smith JC. Differences in outcome of transurethral resection of the prostate for benign prostatic hypertrophy between three-diagnostic categories. Br J Urol 1993; 72: 322-30
62. O'Leary MP, Fowler FJ, Lenderking WR et al. A brief male sexual function inventory for urology. Urology 1995; 46: 697-706
63. Helgason AR. Prostate cancer treatment and quality of life -a three level epidemiological approach [Dissertation]. Kongl Carolinska Medico Chirurgiska Institute, Stockholm 1997
64. Helgason AR, Fredrikson M, Adolfsson J, Steineck G. Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life. Int J Radiation Oncol Biol Phys 1995; 32: 33-9
65. Helgason AR, Adolfsson J, Dickman P et al. Sexual desire, erection, orgasm and ejaculatory functions and their importance to elderly Swedish men: a population-based study. Age Aging 1996; 25: 285-91
66. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G. Waning sexual function - the most important disease-specific distress for patients with prostate cancer. Br J Cancer 1996; 73: 1417-21
67. Helgason AR, Adolfsson J, Dickman P, Arver S, Fredrikson M, Gunnar S. Factors associated with waning sexual function among elderly men and prostate cancer patients. J Urol 1997; 157: 1-5
68. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for the assessment of erectile dysfunction. Urology 1997; 49: 822-30